•  6
    Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives
    with K. S. Rommelfanger, S. J. Jeong, A. Ema, T. Fukushi, K. Kasai, K. M. Ramos, Arleen Salles, Paul Boshears, Global Neuroethics Summit Delegates, and Hagop Sarkissian
    Neuron 100 (1): 19-36. 2018.
    Increasingly, national governments across the globe are prioritizing investments in neuroscience. Currently, seven active or in-development national-level brain research initiatives exist, spanning four continents. Engaging with the underlying values and ethical concerns that drive brain research across cultural and continental divides is critical to future research. Culture influences what kinds of science are supported and where science can be conducted through ethical frameworks and evaluatio…Read more
  •  37
    In this article, I examine children's reported experiences with stimulant drug treatments for attention deficit hyperactivity disorder in light of bioethical arguments about the potential threats of psychotropic drugs to authenticity and moral agency. Drawing on a study that involved over 150 families in the USA and the UK, I show that children are able to report threats to authenticity, but that the majority of children are not concerned with such threats. On balance, children report that stimu…Read more
  •  8
    The VOICES study involved at least one radical move in the decades-old debates about attention deficit hyperactivity disorder diagnosis and stimulant drug treatments: to systematically investigate young people's perspectives and experiences so that these could be included as evidence in social, ethical and policy deliberations about the benefits and risks of these interventions. The findings reported in this article were both surprising and unsurprising to us as researchers. We were surprised at…Read more